大学病院・特殊診療施設

Medicine and Dentistry

1. Neoplasm 100%
2. Blood Pressure 81%
3. Observational Study 74%
4. Primary Hyperaldosteronism 73%
5. Diseases 73%
6. COVID-19 63%
7. Aldosterone 59%
8. Cohort Analysis 58%
9. Magnetic Resonance Imaging 57%
10. Hospital Mortality 55%
11. Kampo 53%
12. Intensive Care Unit 53%
13. Bleeding 48%
14. Patient 48%
15. Computer Assisted Tomography 47%
16. Liver Transplantation 47%
17. Prevalence 46%
18. Inpatient 41%
19. Odds Ratio 39%
20. Malignant Neoplasm 38%
21. Retrospective Cohort Study 35%
22. Lung 34%
23. Living Donors 33%
24. Blood Flow 31%
25. Resuscitation 31%
26. Apoplexy 30%
27. Recurrent Disease 30%
28. Extracorporeal Membrane Oxygenation 29%
29. Pediatrics 28%
30. Neuromyelitis Optica 27%
31. Disease 27%
32. Hydrocortisone 27%
33. Breast Cancer 25%
34. Hemodynamic 25%
35. Sepsis 24%
36. Chronic Kidney Disease 24%
37. Immunohistochemistry 23%
38. Aldosterone Synthase 23%
39. Health Care Cost 23%
40. Propensity Score Matching 23%
41. Adverse Event 23%
42. Adrenal Adenoma 22%
43. Enteric Feeding 21%
44. Esophageal Squamous Cell Carcinoma 21%
45. Tumor Cell 21%
46. Artificial Respiration 21%
47. Multivariate Analysis 20%
48. Blood Pressure Measurement 20%
49. Esophagus 20%
50. Acupuncture 20%
51. Extracorporeal 20%
52. Metastatic Carcinoma 19%
53. Intensive Care 19%
54. Pheochromocytoma 19%
55. Body Mass Index 19%
56. Cancer 19%
57. Randomized Controlled Trial 19%
58. Stenosis 19%
59. Cerebrospinal Fluid 18%
60. Adrenal Gland 18%
61. Biopsy Technique 18%
62. Immunosuppressive Treatment 18%
63. Infection 18%
64. Adrenal Cortex Carcinoma 18%
65. Logistic Regression Analysis 17%
66. Analysis 17%
67. Infusion 17%
68. Hospital 17%
69. Neuroendocrine Tumor 17%
70. Heart Arrest 17%
71. Angioplasty 17%
72. Squamous Cell Carcinoma 17%
73. Gestational Diabetes 16%
74. Therapeutic Procedure 16%
75. Computed Tomography Angiography 16%
76. Medicine 16%
77. Hazard Ratio 16%
78. Chemoradiotherapy 15%
79. Clinical Trial 15%
80. Prognostic Factor 15%
81. Cross Sectional Study 15%
82. Cardiovascular System 15%
83. Messenger RNA 15%
84. Combination Therapy 14%
85. Pulse Rate 14%
86. Craniotomy 14%
87. Embolization 14%
88. Liver Graft 14%
89. Patient Characteristics 14%
90. Dyspnea 14%
91. Morphology 13%
92. Disseminated Intravascular Coagulation 13%
93. Adenocarcinoma 13%
94. Birth Weight 13%
95. Renin 13%
96. Cardiovascular Disease 13%
97. Diabetes 13%
98. Retrospective Study 13%
99. Cushing Syndrome 13%
100. Immunoreactivity 13%

Pharmacology, Toxicology and Pharmaceutical Science

1. Diseases 88%
2. Cohort Study 59%
3. Kampo Medicine (Drug) 47%
4. Observational Study 44%
5. Prevalence 34%
6. Coronavirinae 33%
7. Neoplasm 32%
8. Myelooptic Neuropathy 27%
9. Hospital Mortality 26%
10. Esophageal Squamous Cell Carcinoma 25%
11. Malignant Neoplasm 24%
12. Cerebrovascular Accident 24%
13. Inflammation 23%
14. Antihypertensive Agent 22%
15. Adverse Event 20%
16. Chemotherapy 17%
17. Chronic Kidney Failure 17%
18. Messenger RNA 17%
19. Randomized Controlled Trial 16%
20. Sepsis 15%
21. Cytokine 15%
22. Cardiovascular Disease 14%
23. Hydrocortisone 13%
24. Receptor 13%
25. Combination Therapy 13%
26. Chemoradiation Therapy 13%
27. Diabetes Mellitus 12%
28. Infection 12%
29. Dyspnea 12%
30. Lamb 12%
31. Bleeding 11%
32. Disseminated Intravascular Clotting 11%
33. Syndrome 11%
34. Cross-Sectional Study 11%
35. White Coat Hypertension 11%
36. Normotensive Hydrocephalus 10%
37. Masked Hypertension 10%
38. Premature Labor 10%
39. Pregnancy Diabetes Mellitus 10%
40. Clinical Trial 9%
41. Phenytoin 9%
42. Hospital Mortality 9%
43. Retrospective Study 9%
44. Base 9%
45. Congenital Malformation 9%
46. Antihypertensive Drug 9%
47. Tranexamic Acid 9%
48. Pheochromocytoma 9%
49. Table Salt 9%
50. Chronic Thromboembolic Pulmonary Hypertension 8%
51. Replacement Therapy 8%
52. Aquaporin 4 Antibody 8%
53. Daikenchuto 8%
54. Intracranial Aneurysm 8%
55. Hemodialysis 8%
56. Colorectal Carcinoma 8%
57. Leukemia 8%
58. Cerebrovascular Disease 7%
59. Rat Model 7%
60. Ovine Model 7%
61. Recurrent Disease 7%
62. Multiple Sclerosis 7%
63. SARS Coronavirus 7%
64. Erythropoietin 7%
65. Betamethasone 7%
66. Lymph Node Metastasis 7%
67. Glucocorticoid 7%
68. Heart Muscle Injury 7%
69. Prostate Cancer 7%
70. Lipopolysaccharide 7%
71. Aldosterone 7%
72. Esophagus Cancer 6%
73. Clinical Study 6%
74. Endotoxin 6%
75. Angiotensin Receptor Antagonist 6%
76. Prematurity 6%
77. Biological Marker 6%
78. Myelin Oligodendrocyte Glycoprotein 6%
79. Monotherapy 6%
80. Fibrosis 6%
81. Interleukin 6 6%
82. Yokukansan 6%
83. Aquaporin 4 6%
84. Catecholamine 6%
85. Optic Neuritis 6%
86. Mortality 6%
87. Coughing 6%
88. Creatinine 6%
89. Congestive Heart Failure 6%
90. Protein MDM2 6%
91. Aneurysm Rupture 5%
92. Adrenal Cortex Carcinoma 5%
93. Normal Human 5%
94. Tacrolimus 5%
95. Pneumonia 5%
96. Periodontal Disease 5%
97. Sulfonate 5%
98. Acrylonitrile 5%
99. Thrombopoietin 5%
100. Subdural Hematoma 5%